51. 全身性強皮症 ［臨床試験数：466，薬物数：536（DrugBank：142），標的遺伝子数：110，標的パスウェイ数：210］
Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||EUCTR2019-001279-34-GB||20/08/2019||24/05/2019||A clinical study to test long term safety of GLPG1690 for patients with systemic sclerosis||A multicenter, open-label extension study to evaluate the long-term safety, tolerability and efficacy of orally administered GLPG1690 in subjects with systemic sclerosis||Systemic sclerosis |
MedDRA version: 21.0Level: LLTClassification code 10042953Term: Systemic sclerosisSystem Organ Class: 100000004859;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
|Product Name: GLPG1690|
Product Code: G451990
INN or Proposed INN: ziritaxestat
Other descriptive name: GLPG1690
|Galapagos NV||NULL||Authorised-recruitment may be ongoing or finished||Female: yes|
|30||Phase 2||United States;Spain;Belgium;Germany;Italy;United Kingdom|